Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human immunodeficiency virus envelope glycoproteins

T C Merigan1, S K Kundu

  • 1Center for AIDS Research, Stanford University School of Medicine, CA 94305.

Journal of Acquired Immune Deficiency Syndromes
|January 1, 1994
PubMed
Summary

Therapeutic vaccines aim to control human immunodeficiency virus (HIV) replication. However, viral diversity and immune escape mutants present significant challenges, limiting vaccine impact on viral load.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Feasibility of Trans Radial Percutaneous Coronary Intervention Approach in Elderly Patients with Acute Coronary Syndrome.

Mymensingh medical journal : MMJ·2022
Same author

Impact of Myocardial Blush Grade on In-Hospital Outcome after Primary Percutaneous Coronary Intervention.

Mymensingh medical journal : MMJ·2022
Same author

Serum Albumin Level and In-Hospital Outcome of Patients with First Attack Acute Myocardial Infarction.

Mymensingh medical journal : MMJ·2019
Same author

Combination of Sonodynamic and Photodynamic Therapy against Cancer Would Be Effective through Using a Regulated Size of Nanoparticles.

Nanoscience and nanoengineering·2016
Same author

Relaxation dynamics of liposomes in an aqueous solution.

Physical chemistry chemical physics : PCCP·2015
Same author

Advanced rheological characterization of soft colloidal model systems.

Journal of physics. Condensed matter : an Institute of Physics journal·2012

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Human immunodeficiency virus (HIV) exhibits long clinical latency and high replication rates.
  • HIV persistence involves the generation of diverse viral variants (quasispecies).
  • Therapeutic vaccines aim to enhance immune responses to control HIV replication and disease progression.

Purpose of the Study:

  • To explore challenges in developing effective therapeutic vaccines for HIV.
  • To identify key immune and viral parameters for monitoring therapeutic vaccine efficacy.
  • To assess limitations of current therapeutic vaccine approaches.

Main Methods:

  • Monitoring of HIV-specific cellular and humoral immunity.
  • Assessment of viral load markers.

Related Experiment Videos

  • Evaluation of skin tests for recall antigens.
  • Review of immunogenicity and safety data from phase II/III studies.

    • Main Results:

    • Viral quasispecies diversity and immune escape mutants are major hurdles.
    • Protective immune parameters correlating with disease control are undefined.
    • Reproducible immunogenicity observed mainly in individuals with CD4+ T cells > 400/mm3.
    • No convincing impact on viral load or disease course demonstrated.

    Conclusions:

    • Therapeutic vaccine development for HIV faces significant challenges due to viral diversity and immune evasion.
    • Current monitoring strategies assess various immune and viral markers.
    • Limitations include declining immune response potency and viral escape mutations.
    • Further research is needed to overcome these obstacles for effective HIV therapeutic vaccines.